Annual Accounts Payable
$2.50 M
-$273.00 K-9.85%
December 31, 2024
Summary
- As of February 27, 2025, NVCT annual accounts payable is $2.50 million, with the most recent change of -$273.00 thousand (-9.85%) on December 31, 2024.
- During the last 3 years, NVCT annual accounts payable has risen by +$1.44 million (+136.11%).
- NVCT annual accounts payable is now -14.16% below its all-time high of $2.91 million, reached on December 31, 2022.
Performance
NVCT Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Payable
$2.50 M
+$237.00 K+10.48%
December 31, 2024
Summary
- As of February 27, 2025, NVCT quarterly accounts payable is $2.50 million, with the most recent change of +$237.00 thousand (+10.48%) on December 31, 2024.
- Over the past year, NVCT quarterly accounts payable has dropped by -$273.00 thousand (-9.85%).
- NVCT quarterly accounts payable is now -28.47% below its all-time high of $3.49 million, reached on September 30, 2023.
Performance
NVCT Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
NVCT Accounts Payable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -9.8% | -9.8% |
| 3 y3 years | +136.1% | -28.5% |
| 5 y5 years | +10000.0% | -28.5% |
NVCT Accounts Payable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -14.2% | +136.1% | -28.5% | +136.1% |
| 5 y | 5-year | -14.2% | >+9999.0% | -28.5% | +542.2% |
| alltime | all time | -14.2% | >+9999.0% | -28.5% | +542.2% |
Nuvectis Pharma Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $2.50 M(-9.9%) | $2.50 M(+10.5%) |
| Sep 2024 | - | $2.26 M(+22.5%) |
| Jun 2024 | - | $1.85 M(+4.9%) |
| Mar 2024 | - | $1.76 M(-36.5%) |
| Dec 2023 | $2.77 M(-4.8%) | $2.77 M(-20.6%) |
| Sep 2023 | - | $3.49 M(+93.7%) |
| Jun 2023 | - | $1.80 M(-14.0%) |
| Mar 2023 | - | $2.10 M(-28.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2022 | $2.91 M(+175.0%) | $2.91 M(+29.3%) |
| Sep 2022 | - | $2.25 M(+57.0%) |
| Jun 2022 | - | $1.43 M(+6.3%) |
| Mar 2022 | - | $1.35 M(+27.5%) |
| Dec 2021 | $1.06 M(>+9900.0%) | $1.06 M(+113.7%) |
| Sep 2021 | - | $495.00 K(+27.2%) |
| Jun 2021 | - | $389.00 K |
| Dec 2020 | $10.00 K | - |
FAQ
- What is Nuvectis Pharma annual accounts payable?
- What is the all time high annual accounts payable for Nuvectis Pharma?
- What is Nuvectis Pharma annual accounts payable year-on-year change?
- What is Nuvectis Pharma quarterly accounts payable?
- What is the all time high quarterly accounts payable for Nuvectis Pharma?
- What is Nuvectis Pharma quarterly accounts payable year-on-year change?
What is Nuvectis Pharma annual accounts payable?
The current annual accounts payable of NVCT is $2.50 M
What is the all time high annual accounts payable for Nuvectis Pharma?
Nuvectis Pharma all-time high annual accounts payable is $2.91 M
What is Nuvectis Pharma annual accounts payable year-on-year change?
Over the past year, NVCT annual accounts payable has changed by -$273.00 K (-9.85%)
What is Nuvectis Pharma quarterly accounts payable?
The current quarterly accounts payable of NVCT is $2.50 M
What is the all time high quarterly accounts payable for Nuvectis Pharma?
Nuvectis Pharma all-time high quarterly accounts payable is $3.49 M
What is Nuvectis Pharma quarterly accounts payable year-on-year change?
Over the past year, NVCT quarterly accounts payable has changed by -$273.00 K (-9.85%)